Brookfield Corp’s BioLife Solutions BLFS Stock Holding History

Brookfield Corp’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,033	Closed	-$361K	–	551
2021 Q1	$361K	Sell	10,033 -4,655	-32%	-$184K	﹤0.01%	432
2020 Q4	$586K	Buy	+14,688	New	+$501K	﹤0.01%	404

Other funds holding BLFS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brookfield Corp's BLFS Position: Q2 2021 in Review

Brookfield Corp sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 10,033 shares — an estimated $361K sold.

Brookfield Corp first reported a position in BLFS in Q4 2020 and held it in 2 quarters. The position peaked at $586K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

Brookfield Corp reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
Brookfield Corp sold 10,033 BioLife Solutions shares in Q2 2021, an estimated $361K.
Brookfield Corp first reported a position in BioLife Solutions in Q4 2020 and held it in 2 quarters.
Brookfield Corp's BioLife Solutions position peaked at $586K in Q4 2020.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Brookfield Corp's 13F filing for Q2 2021, filed 17 Aug 2021.